No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IOVA Iovance Biotherapeutics
- 11.640
- -0.160-1.36%
Trading Apr 18 15:15 ET
3.25BMarket Cap-6158P/E (TTM)
11.905High11.475Low2.22MVolume11.680Open11.800Pre Close25.98MTurnover1.05%Turnover RatioLossP/E (Static)279.31MShares18.33052wk High5.56P/B2.46BFloat Cap3.21052wk Low--Dividend TTM210.92MShs Float165.000Historical High--Div YieldTTM3.64%Amplitude1.000Historical Low11.699Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Exelixis Slips as Barclays Downgrades on Lack of Catalysts
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
Better Growth Biotech Buy: Iovance Biotherapeutics Vs CRISPR Therapeutics
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
Iovance Biotherapeutics (NASDAQ:IOVA) Pulls Back 5.6% This Week, but Still Delivers Shareholders Impressive 113% Return Over 1 Year
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) shareholders might be concerned after seeing the share price drop 15% in the last month. But that doesn't change the fact that the returns over the last
Comments
Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:
$SPDR S&P Biotech ETF(XBI.US$
$Merck & Co(MRK.US$ x $Immunovant(IMVT.US$
$Eli Lilly and Co(LLY.US$ x $Cytokinetics(CYTK.US$ (and soon)
$Regeneron Pharmaceuticals(REGN.US$ x $Apellis Pharmaceuticals(APLS.US$ (panache & brash)
$Gilead Sciences(GILD.US$ x %$Madrigal Pharmaceuticals(MDGL.US$ (liver king)
$Bristol-Myers Squibb(BMY.US$ x $Iovance Biotherapeutics(IOVA.US$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US$ x $Merus(MRUS.US$ (partner n...
$Merck & Co(MRK.US$ x $Immunovant(IMVT.US$
$Eli Lilly and Co(LLY.US$ x $Cytokinetics(CYTK.US$ (and soon)
$Regeneron Pharmaceuticals(REGN.US$ x $Apellis Pharmaceuticals(APLS.US$ (panache & brash)
$Gilead Sciences(GILD.US$ x %$Madrigal Pharmaceuticals(MDGL.US$ (liver king)
$Bristol-Myers Squibb(BMY.US$ x $Iovance Biotherapeutics(IOVA.US$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US$ x $Merus(MRUS.US$ (partner n...
2
Update
$Iovance Biotherapeutics(IOVA.US$ Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
4 MINUTES AGO, 6:30 AM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 6:30 AM EST
VIA GLOBENEWSWIRE
4
3
Grateful with whatever the gain though
hhh, reenter.. I should have stopped daytrade better swing for biotech, easier to get gain if got FDA approval...
$Biotechnology(BK2069.US$
$Iovance Biotherapeutics(IOVA.US$
$Biotechnology(BK2069.US$
$Iovance Biotherapeutics(IOVA.US$
2
$Iovance Biotherapeutics(IOVA.US$ well that was scary
2
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg